Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
human embryonic stem cell derived retinal pigmented epithelial cells (1 trial)
valproic acid (depakene) (1 trial)
Retinitis (Phase 2)
Retinitis Pigmentosa (Phase 2)
Trials (2 total)
Trial APIs (2 total)